Omics Approaches in Pancreatic Adenocarcinoma

Omics Approaches in Pancreatic Adenocarcinoma

Pancreatic ductal adenocarcinoma, which represents 80% of pancreatic cancers, is mainly diagnosed when treatment with curative intent is not possible. Consequently, the overall five-year survival rate is extremely dismal—around 5% to 7%. In addition, pancreatic cancer is expected to become the secon...

Full description

Bibliographic Details
Main Authors: Iranzu González-Borja, Antonio Viúdez, Saioa Goñi, Enrique Santamaria, Estefania Carrasco-García, Jairo Pérez-Sanz, Irene Hernández-García, Pablo Sala-Elarre, Virginia Arrazubi, Esther Oyaga-Iriarte, Ruth Zárate, Sara Arévalo, Onintza Sayar, Ruth Vera, Joaquin Fernández-Irigoyen
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Cancers
Subjects:
pancreatic adenocarcinoma
ctDNA
proteomic
genomic
metabolomic
lipidomic
FFPE
tissue
body fluids
Online Access:https://www.mdpi.com/2072-6694/11/8/1052

Similar Items

Similar Items